Pricing
Login
Home
Charts
Search
Watchlist
Products

OneSource Specialty Pharma Ltd

ONESOURCE
₹1,609.30+0.40%20 Nov 2026
Reports
Pharma CRAMS

OneSource Specialty Pharma Ltd

ONESOURCE
₹1,609.30
+0.40%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹18,455Cr
Close
Close Price
₹1,609.30
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
—
PS
Price To Sales
10.96
Revenue
Revenue
₹1,684Cr
Rev Gr TTM
Revenue Growth TTM
10.67%
PAT Gr TTM
PAT Growth TTM
-104.06%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
5673292334393426327376290428449516
Growth YoY
Revenue Growth YoY%
891.0598.4482.412.012.5-26.00.537.237.4
Expenses
ExpensesCr
6776228257251243239269273336326353
Operating Profit
Operating ProfitCr
-10-36477142183881061792123163
OPM
OPM%
-18.7-3.822.023.136.142.927.028.36.021.527.531.6
Other Income
Other IncomeCr
-1053-1-1-94323-22-1-1
Interest Expense
Interest ExpenseCr
262042454633273438233135
Depreciation
DepreciationCr
202068686968687070727275
PBT
PBTCr
-161-40-47-37-6784-46-9302053
Tax
TaxCr
00-4152-16-4-5-4-5-5-5
PAT
PATCr
-130-40-6-42-6999010-8952557
Growth YoY
PAT Growth YoY%
63.047.1345.296.6124.9-28.8-95.313,257.9447.9
NPM
NPM%
-231.6-54.9-1.9-12.6-17.523.1-0.12.8-30.61.15.611.1
EPS
EPS₹
-5.8-9.7-0.1-8.72.98.60.00.9-7.70.42.25.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
5673292334393426327376290428449516
Growth YoY
Revenue Growth YoY%
891.0598.4482.412.012.5-26.00.537.237.4
Expenses
ExpensesCr
6776228257251243239269273336326353
Operating Profit
Operating ProfitCr
-10-36477142183881061792123163
OPM
OPM%
-18.7-3.822.023.136.142.927.028.36.021.527.531.6
Other Income
Other IncomeCr
-1053-1-1-94323-22-1-1
Interest Expense
Interest ExpenseCr
262042454633273438233135
Depreciation
DepreciationCr
202068686968687070727275
PBT
PBTCr
-161-40-47-37-6784-46-9302053
Tax
TaxCr
00-4152-16-4-5-4-5-5-5
PAT
PATCr
-130-40-6-42-6999010-8952557
Growth YoY
PAT Growth YoY%
63.047.1345.296.6124.9-28.8-95.313,257.9447.9
NPM
NPM%
-231.6-54.9-1.9-12.6-17.523.1-0.12.8-30.61.15.611.1
EPS
EPS₹
-5.8-9.7-0.1-8.72.98.60.00.9-7.70.42.25.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
221132391721,4451,4221,684
Growth
Revenue Growth%
1,287.2517.7-70.7344.1740.4-1.610.7
Expenses
ExpensesCr
85932291992609781,1171,288
Operating Profit
Operating ProfitCr
-84-71-97-161-88467304396
OPM
OPM%
-5,444.1-333.6-73.2-415.1-51.332.321.423.5
Other Income
Other IncomeCr
114-142-112-935-2
Interest Expense
Interest ExpenseCr
2816684889166122126
Depreciation
DepreciationCr
2934706676274279288
PBT
PBTCr
-140-121-231-416-366-67-92-20
Tax
TaxCr
00000-50-18-19
PAT
PATCr
-140-121-231-416-366-17-74-2
Growth
PAT Growth%
13.6-91.3-79.812.095.3-327.1-104.1
NPM
NPM%
-9,065.2-564.9-174.9-1,073.6-212.7-1.2-5.2-0.1
EPS
EPS₹
-1,891.4-66.7-65.3-200.9-94.2-1.6-6.4-0.1
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
221132391721,4451,4221,684
Growth
Revenue Growth%
1,287.2517.7-70.7344.1740.4-1.610.7
Expenses
ExpensesCr
85932291992609781,1171,288
Operating Profit
Operating ProfitCr
-84-71-97-161-88467304396
OPM
OPM%
-5,444.1-333.6-73.2-415.1-51.332.321.423.5
Other Income
Other IncomeCr
114-142-112-935-2
Interest Expense
Interest ExpenseCr
2816684889166122126
Depreciation
DepreciationCr
2934706676274279288
PBT
PBTCr
-140-121-231-416-366-67-92-20
Tax
TaxCr
00000-50-18-19
PAT
PATCr
-140-121-231-416-366-17-74-2
Growth
PAT Growth%
13.6-91.3-79.812.095.3-327.1-104.1
NPM
NPM%
-9,065.2-564.9-174.9-1,073.6-212.7-1.2-5.2-0.1
EPS
EPS₹
-1,891.4-66.7-65.3-200.9-94.2-1.6-6.4-0.1
Sales CAGR
1 Year-2%
3 Years232%
5 Years131%
TTM11%
EBITDA CAGR
1 Year-35%
3 Years-
5 Years-
TTM-24%
Avg. ROCE
1 Year0%
3 Years-9%
5 Years-11%
TTM1%
CFO / EBITDA
1 Year3%
3 Years-24%
5 Years-175%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
12344111111
Reserves
ReservesCr
4147741,0097813925,8695,8195,909
Current Liabilities
Current LiabilitiesCr
1941618098656311,1141,4421,664
Non Current Liabilities
Non Current LiabilitiesCr
3613216213582825569371,002
Total Liabilities
Total LiabilitiesCr
9711,2582,4422,0091,3097,5508,2108,586
Current Assets
Current AssetsCr
25995112281761,0861,4261,697
Non Current Assets
Non Current AssetsCr
9471,1591,9311,7801,1326,4646,7846,889
Total Assets
Total AssetsCr
9711,2582,4422,0091,3097,5508,2108,586
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
12344111111
Reserves
ReservesCr
4147741,0097813925,8695,8195,909
Current Liabilities
Current LiabilitiesCr
1941618098656311,1141,4421,664
Non Current Liabilities
Non Current LiabilitiesCr
3613216213582825569371,002
Total Liabilities
Total LiabilitiesCr
9711,2582,4422,0091,3097,5508,2108,586
Current Assets
Current AssetsCr
25995112281761,0861,4261,697
Non Current Assets
Non Current AssetsCr
9471,1591,9311,7801,1326,4646,7846,889
Total Assets
Total AssetsCr
9711,2582,4422,0091,3097,5508,2108,586

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-52-118-416-163-107-689
Investing Cash Flow
Investing Cash FlowCr
-157-207-692-68511-201-495
Financing Cash Flow
Financing Cash FlowCr
653811,162118-391412359
Net Cash Flow
Net Cash FlowCr
-1445654-11213143-127
Free Cash Flow
Free Cash FlowCr
-208-325-1,071-163-107-689
CFO To PAT
CFO To PAT%
37.497.3179.939.229.3392.6-11.6
CFO To EBITDA
CFO To EBITDA%
62.2164.8430.3101.4121.5-14.52.8
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-52-118-416-163-107-689
Investing Cash Flow
Investing Cash FlowCr
-157-207-692-68511-201-495
Financing Cash Flow
Financing Cash FlowCr
653811,162118-391412359
Net Cash Flow
Net Cash FlowCr
-1445654-11213143-127
Free Cash Flow
Free Cash FlowCr
-208-325-1,071-163-107-689
CFO To PAT
CFO To PAT%
37.497.3179.939.229.3392.6-11.6
CFO To EBITDA
CFO To EBITDA%
62.2164.8430.3101.4121.5-14.52.8

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
20,00416,87618,455
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
13.811.911.0
Price To Book
Price To Book
3.42.93.1
EV To EBITDA
EV To EBITDA
43.959.451.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
-812.0-71.519.6-83.134.260.357.257.2
OPM
OPM%
-5,444.1-333.6-73.2-415.1-51.332.321.423.5
NPM
NPM%
-9,065.2-564.9-174.9-1,073.6-212.7-1.2-5.2-0.1
ROCE
ROCE%
-13.9-9.0-7.5-22.3-28.81.50.41.4
ROE
ROE%
-33.7-15.6-22.8-52.9-92.4-0.3-1.30.0
ROA
ROA%
-14.4-9.6-9.5-20.7-27.9-0.2-0.90.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
20,00416,87618,455
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
13.811.911.0
Price To Book
Price To Book
3.42.93.1
EV To EBITDA
EV To EBITDA
43.959.451.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
-812.0-71.519.6-83.134.260.357.257.2
OPM
OPM%
-5,444.1-333.6-73.2-415.1-51.332.321.423.5
NPM
NPM%
-9,065.2-564.9-174.9-1,073.6-212.7-1.2-5.2-0.1
ROCE
ROCE%
-13.9-9.0-7.5-22.3-28.81.50.41.4
ROE
ROE%
-33.7-15.6-22.8-52.9-92.4-0.3-1.30.0
ROA
ROA%
-14.4-9.6-9.5-20.7-27.9-0.2-0.90.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr31,85931,38526,48318,45518,2349,7975,595
Close PriceClose₹239.303,833.5020,642.001,609.30451.70517.60977.80
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE71.4758.5297.5632.3533.56
Price To SalesPS3.2619.7111.4810.965.188.943.00
RevenueRevenueCr9,7791,5932,3071,6843,5221,0961,865
Revenue Growth TTMRev Gr TTM%9.4%45.2%50.5%10.7%-6.0%-7.0%36.8%
PAT Growth TTMPAT Gr TTM%-782.0%95.8%88.4%-104.1%-60.3%-19.0%34.0%
Market CapitalizationMkt CapCr31,85931,38526,48318,45518,2349,7975,595
Close PriceClose₹239.303,833.5020,642.001,609.30451.70517.60977.80
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE71.4758.5297.5632.3533.56
Price To SalesPS3.2619.7111.4810.965.188.943.00
RevenueRevenueCr9,7791,5932,3071,6843,5221,0961,865
Revenue Growth TTMRev Gr TTM%9.4%45.2%50.5%10.7%-6.0%-7.0%36.8%
PAT Growth TTMPAT Gr TTM%-782.0%95.8%88.4%-104.1%-60.3%-19.0%34.0%